HomeDrug recalls
Medium severity

Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr. by Towa Pharmaceutical Eurpoe S.L., Martorelles, (Barcelona), Spain, Dist. by. Breckenridge Pharmaceutical, Inc., Berkely Heights, NJ 07922, NDC 51991-748-90.

SourceFDA Drug Enforcement
CategoryDrug
SeverityMedium
Statusongoing
Recall dateApril 21, 2026
ReportedMay 13, 2026
Recalling firmBreckenridge Pharmaceutical, Inc.
Country / regionUnited States NJ

Hazard

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

Affected products

Related recalls

Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for: OASI · May 20, 2026Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo US · May 20, 2026Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: · May 20, 2026Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Lab · May 13, 2026DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialys · May 13, 2026